Last updated 2026-06-18
- Acquired by Sun Pharma, Jun 2024
Total raised
—
Stage
Acquired
Founded
1959
Headcount
500+
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Taro Pharmaceutical Industries is a research-based international pharmaceutical company manufacturing topical dermatological products and developing a line of solid drugs in cardiology and neurology. Taro synthesizes the active ingredients used in many of its key products. This vertical integration gives Taro control over the manufacturing and quality-control process from the active ingredients to the finished product and provides the company with a competitive advantage in the availability of quality raw materials, the reliability of supply, and the cost of active pharmaceutical ingredients.
Q&A
- What is the current status of Taro Pharmaceutical Industries?
- Taro Pharmaceutical Industries was acquired by Sun Pharma in June 2024.
- Where is Taro Pharmaceutical Industries headquartered?
- Taro Pharmaceutical Industries is headquartered in Haifa, Israel.
- What is Taro Pharmaceutical Industries' primary focus?
- Taro Pharmaceutical Industries is a research-based international pharmaceutical company manufacturing topical dermatological products and developing solid drugs in cardiology and neurology.
- How many employees does Taro Pharmaceutical Industries have?
- Taro Pharmaceutical Industries has over 500 employees.
- What is Taro Pharmaceutical Industries' business model?
- Taro Pharmaceutical Industries operates on a B2B business model.
- Does Taro Pharmaceutical Industries hold any patents?
- Yes, Taro Pharmaceutical Industries holds 1 patent.
- Who is the current CEO of Taro Pharmaceutical Industries?
- Uday Baldota serves as the CEO of Taro Pharmaceutical Industries.
- What is the market capitalization of Taro Pharmaceutical Industries?
- Taro Pharmaceutical Industries has a market capitalization of $1,277,876,352 USD.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsmanufacturinghealthcare-providerstopical-treatmentcardiovascularoral-drugspediatricsdrug-discoveryhospitalsdermatologyanti-inflammatorytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | taro.com |
|---|---|
| linkedin.com/company/13778 |
Identifiers & details
| Founded | 1959-6 |
|---|---|
| Employees (exact) | 1344 |
| Offices | Hawthorne; Brampton |
| Market cap | $1.3B |
| Status reason | Acquired by Sun Pharma on Jun, 2024 |
Acquisitions & public offerings
Acquired by Sun Pharma 2024-06
Radar intelligence
Patents
| EPO | 66 |
|---|
Web history (Wayback)
| Domain | taro.com |
|---|